DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8519281
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8519281
Crilvastatin is an inhibitor of hydroxymethylglutaryl-coenzyme A reductase. In a rat model, the drug was demonstrated to increase low-density lipoprotein (LDL)-cholesterol uptake by the liver more than high-density lipoprotein uptake, thus increasing the clearance of excess plasma cholesterol.
Approval Year
Substance Class |
Mixture
Created
by
admin
on
Edited
Fri Dec 15 17:17:16 GMT 2023
by
admin
on
Fri Dec 15 17:17:16 GMT 2023
|
Record UNII |
D2B8XWK36K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1655
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
120551-59-9
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
PRIMARY | |||
|
C90865
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
PRIMARY | |||
|
D2B8XWK36K
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
PRIMARY | |||
|
EE-4
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
PRIMARY | |||
|
DTXSID101009438
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
PRIMARY | |||
|
SUB06819MIG
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
PRIMARY | |||
|
6623
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL2218880
Created by
admin on Fri Dec 15 17:17:16 GMT 2023 , Edited by admin on Fri Dec 15 17:17:16 GMT 2023
|
PRIMARY |
All of the following components must be present:
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|